Low Density Lipoproteins

Low Density Lipoproteins
Author: Charles Day
Publisher: Springer
Total Pages: 0
Release: 2012-03-22
Genre: Science
ISBN: 9781468422528

Low density lipoproteins (LDL) are pathophysiologically important be cause of their central role in the disease atherosclerosis and because atherosclerosis is the leading cause of death in developed countries. Many researchers believe that a more detailed knowledge of the struc ture, function, and metabolism of LDL may eventually lead to a means to control atherosclerosis. For this reason a fairly large research effort has gone into the investigation of LDL over the past few years. The purpose of this book is to collect and summarize in one place most of the pub lished information on LDL through 1975. To this end more than 1500 references are cited in the papers that make up this volume. The A, B, C apolipoprotein classification system was adopted for use throughout this work. In addition to the A, B, C, and "D" families of apolipoproteins, apoE is used to designate the "arginine-rich" apolipo protein. This classification system is used because it is far less cumber some than other proposed classification schemes for apolipoproteins.

ASD Technical Report

ASD Technical Report
Author: United States. Air Force. Systems Command. Aeronautical Systems Division
Publisher:
Total Pages: 574
Release: 1961
Genre: Aeronautics
ISBN:

High Density Lipoproteins

High Density Lipoproteins
Author: Arnold von Eckardstein
Publisher: Springer
Total Pages: 0
Release: 2015-01-13
Genre: Medical
ISBN: 9783319096643

In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.